Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.
We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.
Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.
Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.
Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.
We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.
Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Citeline
By Doro Shin 26 Apr 2018
The CARE Awards ceremony was held on April 25th at the Boston Harbor Hotel to pay tribute to the people driving the advances in drug development and their commitments to advancing human health. The ceremony was once again hosted by multi-media journalist, Janet Wu, former Anchor and Health Reporter for Boston’s NBC station and adjunct professor at Emerson College
Topic Clinical trials
Citeline
By Loni Branon 26 Apr 2018
The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform.
Topic Clinical trials
Datamonitor Healthcare
By Michael Haydock 26 Apr 2018
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
Scrip
By Jung Won Shin 26 Apr 2018
As political talks gain momentum, the Kaesong Industrial Complex in North Korea could be the starting point of possible healthcare cooperation with the South, once the relationship between the two countries improves, a South Korean official report suggests.
Scrip
By Lucie Ellis 24 Apr 2018
Scrip investigates the big issues Israel's biopharma sector need to overcome in order to maintain momentum and achieve sustainable success.
Topic BioPharmaceutical
Scrip
By John Davis 20 Apr 2018
The sale of the Merck KGaA consumer health business to Procter & Gamble could eventually give the German multinational greater flexibility in business development activities, but reducing net debt has first claim on the funds.
Scrip
By Mike Ward 20 Apr 2018
Denoive acquires from TVM Capital both Biovertis and Morphochem, plus a Phase II ready antibiotic asset, for an initial 4% stake worth €900,000. Since their formation, Biovertis and Morphochem have had more than $96m invested in them.
Datamonitor Healthcare
15 Apr 2018
Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.
Topic Company analysis
Biomedtracker
13 Apr 2018
What’s on the horizon for pharma in 2018? Find out with Biomedtracker’s Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.
Pharmaprojects
By Ian Lloyd 11 Apr 2018
Will the Pharma R&D Annual Review 2018 from Citeline’s Pharmaprojects be music to your ears, or will it sound a sour note? Find out with the Pharma R&D Annual Review 2018 infographic, now available to you as a free download.
Pharmaprojects
By Ian Lloyd 10 Apr 2018
You’ve already tuned into Pharma R&D Annual Review 2018, the free, music-themed whitepaper from Citeline’s Pharmaprojects. Now, get even more free market data and insights with your download of Pharma R&D Annual Review 2018 Supplement: New Active Substances Launched During 2017.
Datamonitor Healthcare
By Jack Allen 09 Apr 2018
Zach McLellan & Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including analysis on Allogene's announcement that they are in-licensing the TALEN technology from Pfizer to commericalise and develop allogeneic, potentially leading to a strong acceleration of CART therapies.
In Vivo
By Ashley Yeo 08 Apr 2018
The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.
Topic Digital Health
Scrip
By Mandy Jackson 06 Apr 2018
Offerings by Homology, Unum and Genprex at the end of March brought the first quarter's biopharma IPO total to 14 in the US, putting 2018 on track to beat the 2017 total of 42. But with the average return for this year's IPOs dropping, the pace of offerings could slow.
Topic Company analysis
Scrip
By Jessica Merrill 06 Apr 2018
CEO Richard Pops called FDA's letter for ALKS 5461 "surprising and troubling." Alkermes had been ramping up to launch the depression drug later this year, though some investors had remained skeptical.
Topic FDA Drug approval
Pink Sheet
26 Apr 2018
Pink Sheet
26 Apr 2018
Pink Sheet
26 Apr 2018
Scrip
26 Apr 2018
Medtech Insight
26 Apr 2018
Scrip
25 Apr 2018
Pink Sheet
25 Apr 2018
Scrip
25 Apr 2018
Pink Sheet
25 Apr 2018
Medtech Insight
25 Apr 2018
Medtech Insight
25 Apr 2018
Medtech Insight
25 Apr 2018
In Vivo
25 Apr 2018
Scrip
25 Apr 2018
In Vivo
25 Apr 2018
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
15 May 2018 , 11:00 EST
Webinar
23 Sep 2018
USA
Awards
09 Oct 2018
Spain
Awards
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
